A preliminary animal study suggests lycopene may help prevent bone loss associated with aging.
Photo © iStockphoto.com/Jasmina007
Researchers have found that lycopene supplementation may help restore bone strength caused by post-menopausal osteoporosis. The findings come out of a new preliminary animal study from Saudi Arabia.
The study included 264 Wistar rats aged six months that were either sham-operated (SHAM) or ovariectomized (OVX) to simulate post-menopausal osteoporosis symptoms. The SHAM group served as a control while the OVX group was randomized to receive oral daily lycopene treatments of 0, 15, 30, or 45 mg/kg body weight per day, or alendronate at 2µg/kg of body weight per day. The supplementation period lasted for 12 weeks.
Researchers measured lycopene’s effect on the rats’ bones by bone densitometry measurements, bone turnover markers, biomechanical testing, histomorphometric analysis, and micro computed tomography (to evaluate changes in microarchitecture).
Lycopene treatment was found to suppress the OVX-induced increase in bone turnover, as evidenced by changes in biomarkers of bone metabolism, including serum osteocalcin, serum N-terminal propeptide of type 1 collagen, serum crosslinked carboxyterminal telopeptides, and urinary deoxypridinoline.
“Significant improvement in OVX-induced loss of bone mass, bone strength, and microarchitectural deterioration was observed in lycopene-treated OVX animals,” wrote the researchers. They also noted that the observed beneficial effects of lycopene supplementation were especially pronounced at sites rich in trabecular bone, and less pronounced in cortical bone.
“These findings demonstrate that lycopene treatment in OVX rats primarily suppressed bone turnover to restore bone strength and microarchitecture,” researchers concluded.
Read more:
Bone-Health Cofactors: New Science on Vitamin D, K2, Magnesium, and Zinc
MSM and Boswellic Acids Comparable to Glucosamine for Osteoarthritis Relief, Study Says
Ingredient Spotlight: Lycopene
Michael Crane
Associate Editor
Nutritional Outlook Magazine
michael.crane@ubm.com
Ardawi MS et al., “Lycopene treatment against loss of bone mass, microarchitecture and strength in relation to regulatory mechanisms in a postmenopausal osteoporosis model,” Bone, vol. 83 (February 2016): 127-140
Nutritional Outlook's Women in Nutraceuticals Roundtable: The Future of Women's Health Research
July 19th 2024Watch "The Future of Women's Health Research," a roundtable discussion presented by Nutritional Outlook in partnership with Women in Nutraceuticals. This roundtable is supplement to a recent article commissioned by WIN and published by Nutritional Outlook, titled “Taking Initiative: Can the WHI’s model help the nutraceutical industry answer questions the study didn’t even ask?”
Recent animal study finds that Lysoveta may help reduce neonatal brain injury
July 17th 2024A recent animal study found that lysophosphatidylcholine (LPC)-bound omega-3 long-chain polyunsaturated fatty acids (LCPUFAs), marketed as Lysoveta by Aker BioMarine, protected against neonatal hypoxic-ischemic (HI) brain injury in mice.